MIRAE ASSET
HEALTHCARE FUND - (MAHCF)

(Sectoral/Thematic Fund - An open ended equity scheme investing in healthcare and allied sectors)
Details as on November 30, 2023
Type of Scheme Sectoral/Thematic Fund - An open ended equity scheme investing in healthcare and allied sectors
Investment Objective The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
Fund Manager**
Mr. Vrijesh Kasera
(since July 02, 2018)
Allotment Date 02nd July, 2018
Benchmark Index S&P BSE Healthcare Index (TRI)
Minimum Investment
Amount
₹ 5,000/- and in multiples of ₹ 1/-thereafter. Minimum Additional Application Amount: ₹ 1,000/- per application and in multiples of ₹ 1/- thereafter.
Systematic Investment
Plan (SIP)
(Any Date SIP is available from 1st July, 2019)
Monthly and Quarterly: ₹ 1,000/- (multiples of ₹ 1/- thereafter), minimum 5 in case of Monthly or 3 in case of Quarterly option.
Load Structure Entry load: NA
Exit load:
I. For investors who have opted for SWP under the plan:
a) 15% of the units allotted (including Switch-in/STP - in) on or before completion of 365 days from the date of allotment of units: Nil.
b) Any redemption in excess of such limits in the first 365 days from the date of allotment shall be subject to the following exit load: (Redemption of units would be done on First In First Out Basis (FIFO):
•If redeemed within 1 year (365 days) from the date of allotment: 1%
•If redeemed after 1 year (365 days) from the date of allotment: NIL
II. Other Redemptions: For Investors who have not opted for SWP under the plan (including Switch out, STP out):
•If redeemed within 1 year (365 days) from the date of allotment: 1%
•If redeemed after 1 year (365 days) from the date of allotment: NIL
Plans Available Regular Plan and Direct Plan
Options Available Growth Option and IDCW Option (Payout & Re-investment)
Monthly Average AUM
(₹ Cr.) as on November 30, 2023
1,896.32
Net AUM (₹ Cr.) 1,974.05
Monthly Total Expense Ratio
(Including Statutory Levies)
as on November 30, 2023
Regular Plan: 2.03%
Direct Plan: 0.54%
**For experience of Fund Managers Click Here
NAV: Direct Regular
Growth ₹ 29.899 ₹ 27.465
IDCW ₹ 23.104 ₹ 20.732
New Position Bought
Stock
Pharmaceuticals & Biotechnology
J B Chemicals and Pharma Ltd
Positions Increased
Stock
Healthcare Services
Dr. Lal Path Labs Limited
Pharmaceuticals & Biotechnology
Cipla Limited
Divi's Laboratories Limited
Gland Pharma Limited
Positions Decreased
Stock
Healthcare Services
Apollo Hospitals Enterprise Limited
Krishna Institute Of Medical Sciences Limited
Insurance
ICICI Lombard General Insurance Company Limited

Portfolio Holdings % Allocation
Pharmaceuticals & Biotechnology  
Sun Pharmaceutical Industries Limited 15.42%
Cipla Limited 9.33%
Dr. Reddy's Laboratories Limited 8.28%
Aurobindo Pharma Limited 7.80%
J B Chemicals and Pharma Ltd 5.16%
Torrent Pharmaceuticals Limited 3.99%
Lupin Limited 3.54%
Gland Pharma Limited 3.27%
Biocon Limited 3.24%
Alkem Laboratories Limited 2.56%
Divi's Laboratories Limited 2.54%
Ajanta Pharma Limited 2.27%
Concord Biotech Limited 2.07%
IPCA Laboratories Limited 1.86%
Mankind Pharma Limited 1.62%
Sanofi India Limited 0.92%
Natco Pharma Limited 0.87%
Abbott India Limited 0.00%
Healthcare Services  
Apollo Hospitals Enterprise Limited 6.24%
Krishna Institute Of Medical Sciences Limited 5.93%
Fortis Healthcare Limited 3.60%
Syngene International Limited 2.06%
Dr. Lal Path Labs Limited 1.48%
Jupiter Life Line Hospitals Limited 0.55%
Chemicals & Petrochemicals  
Vinati Organics Limited 1.42%
Tatva Chintan Pharma Chem Limited 1.11%
Insurance  
Max Financial Services Limited 1.56%
ICICI Lombard General Insurance Company Limited 0.88%
Equity Holding Total 99.57%
Cash & Other Receivables 0.43%
Total 100.00%

Growth of Rs. 10,000 invested at inception: 27,465

Returns (in%)
1 Yr 3 Yrs 5 Yrs SI
MAHCF 24.12% 15.74% 21.25% 20.51%
Scheme Benchmark* 27.78% 15.09% 17.01% 16.28%
Additional Benchmark** 7.59% 16.32% 14.46% 13.95%
NAV as on 30th November, 2023 ₹ 27.465
Index Value ( 30th November, 2023) Index Value of Scheme benchmark is 34,848.96 and S&P BSE Sensex (TRI) is 1,02,618.94
Allotment Date 02nd July, 2018
Scheme Benchmark *S&P BSE Healthcare Index (TRI)
Additional Benchmark **S&P BSE Sensex (TRI)

Fund manager : Mr. Vrijesh Kasera managing the scheme since July 02, 2018
Note: Returns below or for 1 year are absolute returns, returns above 1 year are CAGR- Compounded Annualized Growth returns.
Latest available NAV has been taken for return calculation wherever applicable

Past Performance may or may not be sustained in future. Note : For computation of since inception returns (%) the allotment NAV has been taken as ₹ 10.00. The performance of other funds managed by the same fund manager is given in the respective page of the schemes
Different Plans under the scheme has different expense structure. The reference and details provided here in are of Regular Plan - Growth Option

Period Total Amount Invested Mkt Value as on
30-November-2023
SI
6,40,000 11,31,951
5 Yrs
6,00,000 10,28,450
3 Yrs
3,60,000 4,57,061
1 Yr
1,20,000 1,47,230

Returns (%)
Period
SI
5yrs
3yrs
1yr
Fund Return& (%)
21.45 21.72 16.15 44.75
Benchmark Return& (%)
19.26 19.93 17.09 48.57
Add. Benchmark Return& (%)
15.39 15.69 12.43 14.92

& The SIP returns are calculated by XIRR approach assuming investment of ₹ 10,000/- on the 1st working day of every month.

Regular Plan
Record Date Quantum
(₹ per unit)
Face Value
(₹ per unit)
NAV
(₹ per unit)
14-Feb-23
1.70
10.00
17.300
Direct Plan
Record Date Quantum
(₹ per unit)
Face Value
(₹ per unit)
NAV
(₹ per unit)
14-Feb-23
1.55
10.00
18.730

Past Performance may or may not be sustained in future. Pursuant to payment of IDCW the NAV of the IDCW option of the scheme will fall to the extent of payout and statutory levy (if any). IDCW history is for MAHCF - Regular & Direct Plan - IDCW Option

Volatility 16.02%
Beta 0.94
R Squared 0.97
Sharpe Ratio# 0.55
Information Ratio 0.22
Portfolio Turnover Ratio 0.19 times

@The Volatility, Beta, R Squared, Sharpe Ratio & Information Ratio are calculated on returns from last three years Monthly data points. # Risk free rate: FBIL OVERNIGHT MIBOR as on 30th November, 2023.^Basis last rolling 12 months.

This product is suitable for investors who are seeking*
• To generate long term capital appreciation
• Investments in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sector in India

*Investors should consult their financial advisers if they are not clear about the suitability of the product.